期刊文献+

高迁移率蛋白A2和血管内皮生长因子在膀胱癌中的表达及意义 被引量:1

The expression and significance of HMGA2 and VEGF in tumorigenesis and recurrence of bladder urothelial carcinoma
下载PDF
导出
摘要 目的研究高迁移率蛋白A2(HMGA2)和血管内皮生长因子(VEGF)在膀胱尿路上皮癌中发生及复发中的表达及其意义。方法应用免疫组织化学技术检测63例膀胱尿路上皮癌组织中HMGA2和VEGF的表达,其中复发膀胱尿路上皮癌21例。结合临床病理资料进行统计学分析。结果 63例膀胱癌标本中HMGA2和VEGF的表达明显升高,与膀胱癌组织的病理分级、临床分期及复发有关,且HMGA2和VEGF的表达呈正相关,差异有统计学意义(P<0.05)。与未复发组相比,21例复发膀胱尿路上皮癌中HMGA2和VEGF的表达明显升高(P<0.05)。复发膀胱尿路上皮癌中HMGA2与VEGF的表达呈正相关。结论 HMGA2与VEGF在膀胱尿路上皮癌中表达增高,与膀胱尿路上皮癌的复发和转移密切相关。 [ Objective ] To investigate the expression and the significance of HMGA2 and VEGF in the develop- ment and recurrence of bladder urothelial carcinoma. [Methods] 10 cases of normal bladder tissues were treated as a control. The immunohistochemistry technique was used to analyze the expression of the HMGA2 and VEGF in 63 bladder urothelial carcinoma combined with the clinical data. In 21 eases of recurrent bladder urothelial carcinoma tissues, the expression of the HMGA2 and VEGF was also investigated. [Results] We confirmed that the expression of the HMGA2 and VEGF in the 63 cases of bladder urothelial carcinoma increased significantly, and it was related with the pathological grade, clinical stage and recurrence (P 〈0.05). There was a positive correlation between HMGA2 and VEGF. Likewisely, HMGA2 and VEGF in the 21 recurrent cases increased significantly compared with the control group (P 〈0.05). [ Conclusion ] The expression of HMGA2 and VEGF was elevated in the bladder urothelial carcinoma. They are closely related with the recurrence and tumorigenesis of bladder urothelial carcinoma.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2014年第31期34-38,共5页 China Journal of Modern Medicine
基金 徐州市科技局基金资助项目(No:XF10C036)
关键词 膀胱尿路上皮癌 高迁移率蛋白A2 血管内皮生长因子 发生 复发 bladder urothelial carcinoma HMGA2 VEGF tumorigenesis recurrence
  • 相关文献

参考文献16

  • 1GIACOMO CATFARUZZI, SANDRO ALTAMURA, MICHELA A TESSARI, et at. The second AT-hook of the architectural tran- scription factor HMGA2 is determinant for nuclear localization and function[J]. Nucleic Acids Research, 2007, 35(6): 1751-1760.
  • 2MEYER B, LOESCHKE S, SCHULTZE A, et at. HMGA2 over- expression in non-small cell lung cancer[J]. Molecular Carcino- genesis, 2007, 46(7): 503-511.
  • 3ABE N, WATANABE T, SUZUKI Y, et at. An increased high-mobility group A2 expression level is associated with ma- lignant phenotype in phenotype in pancreatic exocrine tissue[J]. Br J Cancer, 2003, 89(11): 2104-2109.
  • 4HETLAND TE, HOLTH A, KAERN J, et al. HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumor, and solid metastases[J]. Virchows Archiv, 2012, 460(5): 505-513.
  • 5DEMARTINO I, VISONE R, WIERINCKX A, et at. HMGA pro- teins up regulate CCNB2 gene in mouse and human pituitary adenomas[J]. Cancer Res, 2009, 69(5): 1844-1850.
  • 6TESSAR IM A, GOSTISSA M, ALTAMURA S, et at. Transcrip- tional activation of the cyclin A gene by the architectural tran- scription factor HMGA2[J]. Mol Cell Biol, 2003, 23(24): 9104- 9116.
  • 7BORRMANN L, SCHWANBECK R, HEYDUK T, et al. High mobility group A2 protein and its derivatives bind a specific re- gion of the promoter of DNA repair gene ERCC1 and modulate its activity[J]. Nucleic Acids Res, 2003, 31(23): 6841-6851.
  • 8E-JEAN TAN, SYLVIE THUAULT, LAIA CAJA, et al. Regula- tion of transcription factor twist expression by the DNA architec- tural protein high mobility group A2 during epithelial-to-mes- enchymal transition[J]. The Journal of Biological Chemistry, 2012, 287(10): 7134-7145.
  • 9WATANABE S, UEDA Y, AKABOSHI S, et at. HMGA2 main- tains oncogenic ras-induced epithelial-mesenchymal transition in human pancreatic cancer cells[J]. The American Journal of pathol- ogy, 2009, 174(3): 854-868.
  • 10ZHA L, WANG Z, TANG W. et al. Genome-wide analysis of HMGA2 transcription factor binding sites by ChIP on chip in gastric carcinoma cells[J]. Mol Cell Biochem, 2012, 364(1-2): 243-251.

二级参考文献31

  • 1温机灵,周祥福,冯智英,黄文涛,张涛,蔡育彬,高新.p53、p21、Ki-67和VEGF与膀胱癌分级、分期以及预后的关系[J].临床泌尿外科杂志,2007,22(5):328-331. 被引量:14
  • 2Fusco A, Fedele M. Roles of HMGA proteins in cancer [J]. Nat Rev Cancer, 2007, 7(12): 899- 910.
  • 3Hock R, Furusawa T, Ueda T, et al. HMG chro- mosornal proteins in development and disease [J].Trends Cell Biol, 2007, 17(2):72-79.
  • 4Cleynen I, Vandeven WJ. The HMGA proteins: a myriad of functions [J]. Int J Oncol, 2008, 32(2) : 289-305.
  • 5Sgarra R, Zammitti S, Lo Sardo A, et al. HMGA molecular network: From transcriptional regulation to chromatin remodeling [J].Biochim Biophys Ac ta, 2010, 1799(1/2):37-47.
  • 6Fedele M, Battista S, Kenyon L, et al. Overex- pression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas[J]. Oncogene, 2002, 21 (20): 3190-3198.
  • 7Fedele M, Palmieri D, Fusco A. HMGA2: A pitui- tary tumour subtype-specific oncogene[J]? Mol Cell Endocrinol, 2010, 326(1/2) 19-24.
  • 8Meyer B, Loeschke S, Schultze A, et al. HMGA2 overexpression in non-small cell lung cancer [J]. Mol Carcinog, 2007, 46(7) 503-511.
  • 9Sarhadi VK, Wikman H, Salmenkivi K, et al. In creased expression of high mobility group A pro teins in lung cancer [J].J Pathol, 2006, 209(2) 206-212.
  • 10Yang GL, Zhang LH, Bo JJ, et al. Overexpression of HMGA2 in bladder cancer and its association with clinicopathologic features and prognosis HM- GA2 as a prognostic marker of bladder cancer[J]. EurJ Surg Oncol, 2011, 37(3): 265-271.

共引文献9

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部